EFFECT OF NERVE BLOCKADE ON PULSATILE INSULIN AND GLUCAGON-SECRETION INVITRO

被引：13

作者：

OPARA, EC

GO, VLW

机构：

[1] Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

[2] Department of Medicine, UCLA School of Medicine, University of California, Los Angeles, CA

来源：

PANCREAS | 1991年 / 6卷 / 06期

关键词：

INSULIN; GLUCAGON; TETRODOTOXIN; GLYBURIDE; ISOLATED ISLETS;

D O I：

10.1097/00006676-199111000-00006

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

We recently reported that the secretion of insulin and glucagon by isolated murine islets is pulsatile and suggested that the pacemaker controlling these hormone oscillations is present in the islet. In the present study, we tested the hypothesis of an intrinsic islet neural controlling mechanism for the observed hormone pulsatility. Nerve blockade was attempted by infusion of tetrodotoxin (TTX) on a background of combined adrenergic and cholinergic blockade with atropine, propranolol, and phentolamine, (ATX). Because TTX acts by blocking Na+ channels, we also studied the effects of other cationic channel manipulations on the amplitude and frequency of the oscillations. The normal frequency and amplitude of glucagon and insulin oscillations were not affected by ATX. In contrast, TTX infusion increased the amplitude of insulin (198.6 +/- 20.9 vs. 507.2 +/- 62.8 pg/min, p < 0.05, n = 4) and shortened the period from 5.03 +/- 0.26 to 3.33 +/- 0.0 min without affecting glucagon cycles. Whereas the Ca2+ ionophore A23187 had no effect on either hormone oscillation, the ATP-sensitive K+ channel blocker glyburide only increased the amplitude of insulin and decreased the amplitude of glucagon, without altering the frequencies. These data suggest that an intrinsic autonomously functioning islet nervous system is the pacemaker for the insulin oscillations and that the control of glucagon cycles differs from that of insulin.

引用

页码：653 / 658

页数：6

共 35 条

[1]

Weigle D.W., Pulsatile secretion of fuel-regulation hormones, Diabetes, 36, pp. 764-775, (1987)

[2]

Lefebvre P.J., Paolisso G., Scheen A.J., Henquin J.C., Pulsatility of insulin and glucagon release: Physiological significance and pharmacological implications, Diabetologia, 30, pp. 443-452, (1987)

[3]

Matthews D.R., Naylor B.A., Jones R.G., Ward G.M., Turner R.C., Pulsatile insulin has greater hypoglycemic effects than continuous delivery, Diabetes, 32, pp. 617-621, (1983)

[4]

Paolisso G., Sgambato S., Torella R., Et al., Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type I diabetes, J Clin Endocrinol Metab, 66, pp. 1220-1226, (1987)

[5]

Polonsky K.S., Given B.D., Hirsch L.J., Et al., Abnormal pat-terns of insulin secretion in non-insulin-dependent diabetes insulin, N Engl J Med, 318, pp. 1231-1239, (1988)

[6]

Weigle D.S., Koerker D.J., Goodner D.J., Pulsatile glucagon delivery enhances glucose production by perifused rat hepatocytes, Am J Physiol, 247, pp. E564-E568, (1984)

[7]

Campbell P.J., Bolli G.B., Gerich J.E., Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion, N Engl J Med, 321, pp. 1473-1479, (1985)

[8]

Fijita T., Histological studies on the neuroinsular complex in the pancreas of some animals, Z Zellforsch Mikrosk Anat, 50, pp. 94-149, (1959)

[9]

Miller R.E., Pancreatic neuroendocrinology: Peripheral, neural mechanism in the regulation of the islets of Langerhans, Endocrine Res, 2, pp. 471-484, (1981)

[10]

Stagner J.L., Samols E., Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas, Am J Physiol, 248, pp. E516-E521, (1985)

← 1 2 3 4 →